One Wealth Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
One Wealth Capital Management's VRTX Position: Q2 2026 in Review
One Wealth Capital Management increased its Vertex Pharmaceuticals (VRTX) stake by 102% in Q2 2026, buying an estimated $878K and bringing the position to 3,916 shares worth $1.95M. The position accounts for 0.55% of the portfolio, ranked #37.
One Wealth Capital Management first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- One Wealth Capital Management held 3,916 shares of Vertex Pharmaceuticals worth $1.95M as of Q2 2026.
- One Wealth Capital Management bought 1,980 Vertex Pharmaceuticals shares in Q2 2026, an estimated $878K.
- Vertex Pharmaceuticals made up 0.55% of One Wealth Capital Management's portfolio in Q2 2026, its #37 holding.
- One Wealth Capital Management first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
- 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on One Wealth Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.